Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...

Three Johns Hopkins experts discuss the potential of mRNA-powered therapeutics to produce lifesaving treatments and cures for ...

Researchers from the University of Birmingham have uncovered answers that provide the detail to explain two specific DNA ...

Companies are exploring self-amplifying and circular mRNA structures, which can increase protein expression and require lower doses, reducing cost and side effects. Novel delivery systems ...

ToolGen, Inc. (KOSDAQ 199800), led by CEO Jong Sang Ryu and recognized as a global leader in genome editing technology, announced today that it has filed a patent infringement lawsuit in the United ...

Another reason for choosing a particular modality is that it is a team’s specialty. Strategic choices can be less about ...

There are at least 5 Israeli companies advancing human-centric care using AI of at least 1800 in biotechnology. Overseas ...

ToolGen commences legal action in UK court over Vertex's genome editing therapy, CASGEVY ®Seeks to expand licensing of its proprietary CRISPR RNP technologySEOUL, South Korea, April 21, 2025 /PRNewswi ...

One concern with in vivo CAR-Ts is the potential insertional mutagenesis of the lentiviral DNA payload, causing secondary ...

Getting therapeutic drugs past the blood-brain barrier has long been a major challenge in treating brain diseases. Now, researchers have explored how cholesterol-modified heteroduplex oligonucleotides ...

The research team found that a specific muscle protein, known as MEF2C, is significantly reduced in muscle cells with CP.

In this webinar, Benoit Derrien will discuss new strategies using enzymatically synthesized DNA for gene construction.